Our findings showed that SLC11A1 rs3731865 G/C is associated with an increased risk of T2DM in our population, while SLC11A1 rs3731864 G/A and rs17235416 + TGTG/−TGTG SNPs were correlated to decreased risk of developing this endocrine disease. Here, SLC11A1 is linked to endocrine system disorder.